503A Chain-of-Custody Supply
The Complete Chain-of-Custody Difference for 503A Compounding
Most wholesale peptide API suppliers provide a Certificate of Analysis. What differentiates Wholesale Peptide Distributors for 503A compounding pharmacies is the completeness of the documentation chain — tracing every lot from the FDA green list raw material supplier through US synthesis in an ISO 5 cleanroom, through quality release, and to your pharmacy's receiving dock. No gaps. No unverified raw material sources. No imported finished product.
Our chain-of-custody package for 503A pharmacy buyers includes: green list supplier qualification records (confirming raw API is from an FDA import alert green list manufacturer), synthesis batch records, ISO 5 cleanroom environmental monitoring data, in-process quality control documentation, HPLC purity report (≥99%), mass spectrometry identity confirmation, endotoxin testing per LAL method, residual solvent testing per USP <467>, and cold-chain temperature logs from our facility to your dock. This is the complete documentation picture your QA pharmacist and state board need.
Why does chain-of-custody matter so much for 503A compounding? Because the risk in peptide API sourcing is not just in the finished compound purity — it's in the raw material origin and manufacturing conditions. A peptide with 99% HPLC purity that was synthesized in a general laboratory from unverified overseas raw material presents a fundamentally different risk profile than the same compound synthesized in an ISO 5 US cleanroom from FDA green list API. Wholesale Peptide Distributors eliminates that ambiguity.
Our 503A pharmacy onboarding process verifies your state pharmacy license, DEA registration, and pharmacist-in-charge credentials within 24–48 hours. Once approved, your account portal provides per-lot CoA access, chain-of-custody document downloads, and inventory management tools designed for compounding pharmacy procurement teams. See our full quality standards or contact our pharmacy team to request a documentation sample package.
- Chain-of-custody from FDA green list raw material through ISO 5 US synthesis
- Green list supplier qualification records available per lot
- ISO 5 cleanroom synthesis (≤100 particles/ft³ ≥0.5µm)
- HPLC purity ≥99% with full chromatogram per lot
- Endotoxin testing (LAL, <10 EU/mg) — USP Chapter <797> compliant
- Residual solvent testing (USP <467>) per lot
- Cold-chain temperature logs from our facility to your dock
- Account portal CoA and chain-of-custody document access